Generic

India is the world's largest producer and exporter of generic drugs. But how did it manage to do so? Let us find out here

Biosimilars have the potential to offer affordable treatment to many currently untreatable diseases but striking a balance between affordability and regulation will be crucial

Players say low prescription, double-digit price erosion are key reasons

The company has been awarded with new work orders worth Rs 80.80 crore (including GST) for various institutional projects from new reputed clients

While India business disappointed, lower expenses helped margins

This is for the generic version of a popular drug for multiple sclerosis, Copaxone 40 mg